Increased myeloperoxidase plasma levels in patients with Alzheimer's disease.

@article{Tzikas2014IncreasedMP,
  title={Increased myeloperoxidase plasma levels in patients with Alzheimer's disease.},
  author={Stergios Tzikas and Dennis Schlak and Kateryna Sopova and Aikaterini Gatsiou and Dimitrios A. Stakos and Kimon Stamatelopoulos and Konstantinos Stellos and Christoph Laske},
  journal={Journal of Alzheimer's disease : JAD},
  year={2014},
  volume={39 3},
  pages={557-64}
}
BACKGROUND Increasing evidence supports the role of cardiovascular risk factors in the development of Alzheimer's disease (AD). OBJECTIVE In the present pilot study, we investigated plasma concentrations of myeloperoxidase (MPO) and its possible association with plasma amyloid-β (Aβ)1-42/1-40 ratio in AD patients and elderly healthy controls. METHODS The study sample included 28 AD patients and 27 elderly individuals with a normal cognitive status as a control group. The Mini-Mental Status… CONTINUE READING

From This Paper

Topics from this paper.
12 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Similar Papers

Loading similar papers…